Last reviewed · How we verify
EBViNT Cell
At a glance
| Generic name | EBViNT Cell |
|---|---|
| Also known as | Eutil autologous blood-derived T lymphocytes |
| Sponsor | Eutilex |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EBViNT Cell CI brief — competitive landscape report
- EBViNT Cell updates RSS · CI watch RSS
- Eutilex portfolio CI